FASN and prostate carcinoma: Therefore, FASN-targeted therapy would be an effective treatment for complementing hormone therapy against FASN-positive prostate cancers with aggressive features and [1-11C]acetate PET could be applied to select the patients who can undergo the FASN-targeted therapy.